Innovative Learning Disabilities diagnosis and therapy process through AI and Gamification
VISION & PHILOSOPHY
At Oppimi we are using AI for creating innovative clinically-validated Digital Health Tools for diagnosing and treating children that are affected by learning disabilities, through video game environments.
OUR APPROACH
We are providing a full ecosystem that connects learning disabilities specialists, teachers and children’s parents, while given them access to test content and results, therapy advancement details and high-quality analytics.
PARTNERS
ACHIEVMENTS
Mr Kim Tun Lau appointed as Board Member
Exciting News!
We’re thrilled to announce the appointment of Kim Tun Lau as Oppimi new Board Member.
“We are excited to announce the addition of this very accomplished healthcare and pharmaceutical industries leader to Oppimi,” said Ervin Ukaj, Chairman and Chief Executive Officer of Oppimi. “His guidance and expertise will be instrumental as we continue the development of our supportive digital ecosystem for learning disabilities and new product pipeline.”
Mister Kim Tun Lau is a key founding member of JIDA pharmaceutical and Jiwa Bio-Pharm Holdings. He has more than 15 years experience in the healthcare industry and pharma sector for China market. As CEO of JIDA for the last 15 years, he expend the group from ground to a regional pharmaceutical company of 2,000 employees and a revenue of RMB 1.5 Billion. He is also Vice Chairman and CEO of Jiwa; Mr Kim Tun Lau is a very active member of theses industries.
About Oppimi
Oppimi supports test and treatment for children affected by learning disabilities with innovative diagnosis and therapy digital products through AI and Gamification. We are using AI for creating clinically-validated Digital Health Products for diagnosing and treating children that are affected by learning disabilities.
Ai is changing drastically how health is approching LDs, and we are enbracing big data as core. Oppimi’s algorithms, based on machine learning techniques, are able to monitor patient’s advancements and suggest new tasks for optimizing the training results. We are providing a full ecosystem that connects learning disabilities specialists, teachers and children’s parents.
Children have access from their home, while parents can consult therapy advancement and doctors, high-quality analytics. We strive to test our products at multiple levels including with a strong methodology and structured specialists validations. Then the game itself is build in respect of fair game rules without violence and in respect of clean game mechanics.
Seed Investment
Getting the wheel rolling is a priority for Oppimi, now that core team is setup. We found in Pu-Ying Olicom the right investor, to make real things happen. We were looking for active investors can can help us extend our network, especially on China market. Great fit with Pu-Ying Olicom, who are very active in leveraging our entry onto Asian market and accelerating research and development.
Rotaract Partner
Start supporting children
Oppimi signed 2 years contract with Rotaract:Rotary Romania for the largest pilot phase of Oppimi’s Dysgraphia Platform. Thanks to Rotaract Volunteers, we will present our platform to Romanian schools and with them, on coming September 2017, we will start the first Oppimi Pilot in Europe.
NEWS
Mr Kim Tun Lau appointed as Board Member
Exciting News! We’re thrilled to announce the appointment of Kim Tun Lau as Oppimi new Board Member. “We are excited to announce the addition of this very accomplished healthcare and pharmaceutical industries leader to Oppimi,” said Ervin Ukaj, Chairman and Chief Executive Officer of Oppimi. “His guidance and expertise will be instrumental as we continue […]
Pilot with Finland Torkinmäki school
We are glad to announce the formalisation of our collaboration in Finland with Kokkola school Torkinmäki, Microsoft Flux and OppimiGroup.
New collaboration with TimeLink China
Oppimi and TimeLink are taking the next step forward in the future of Education technology and in learning disability diagnosis and treatment process.
Contact Us
Having questions, need more information, interested in a partnership, please hit the button below